1. INTRODUCTION 1.1 MARKET DEFINITION 2. RESEARCH METHODOLOGY 3. EXECUTIVE SUMMARY 4. KEY INFERENCES 5. MARKET OVERVIEW 5.1 CURRENT MARKET SCENARIO 5.2 PORTER'S FIVE FORCES ANALYSIS 5.2.1 BARGAINING POWER OF SUPPLIERS 5.2.2 BARGAINING POWER OF CONSUMERS 5.2.3 THREATS OF NEW ENTRANTS 5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES 5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY 6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC) 6.1 MARKET DRIVERS 6.1.1 INCREASING INCIDENCE OF CARDIOVASCULAR DISEASES 6.1.2 INCREASING RESEARCH FUNDING 6.1.3 RISING AWARENESS OF NANOMEDICINE APPLICATION 6.1.4 RISING GERIATRIC POPULATION 6.2 MARKET RESTRAINTS 6.2.1 HIGH COSTS OF NANOTECHNOLOGY-BASED MEDICAL DEVICES 6.2.2 TIME-CONSUMING PRODUCT APPROVAL 6.3 OPPORTUNITIES 6.4 KEY CHALLENGES 7. MARKET SEGMENTATION 7.1 SEGMENTATION-BY APPLICATIONS 7.1.1 DRUG DELIVERY 7.1.2 DRUGS 7.1.3 BIOMATERIALS 7.1.4 ACTIVE IMPLANTS 7.1.5 IN-VITRO DIAGNOSTIC 7.1.6 IN-VIVO IMAGING 7.2 BY DISEASE 7.2.1 NEUROLOGICAL DISEASES 7.2.2 CARDIOVASCUAR DISEASES 7.2.3 ONCOLOGY 7.2.4 DISPOSABLE IVD DEVICES 7.2.5 ANTI-INFLAMMATORY 7.2.6 ANTI-INFECTIVE 7.2.7 OTHERS 7.3 SEGMENTATION-BY GEOGRAPHY 7.3.1 NORTH AMERICA 7.3.1.1 UNITED STATES 7.3.1.2 CANADA 7.3.1.3 MEXICO 7.3.2 EUROPE 7.3.2.1 FRANCE 7.3.2.2 GERMANY 7.3.2.3 UNITED KINGDOM 7.3.2.4 ITALY 7.3.2.5 SPAIN 7.3.2.6 REST OF EUROPE 7.3.3 ASIA-PACIFIC 7.3.3.1 CHINA 7.3.3.2 JAPAN 7.3.3.3 INDIA 7.3.3.4 AUSTRALIA & NEW ZEALAND 7.3.3.5 SOUTH KOREA 7.3.3.6 REST OF ASIA-PACIFIC 7.3.4 MIDDLE EAST & AFRICA 7.3.4.1 GCC 7.3.4.2 SOUTH AFRICA 7.3.4.3 REST OF THE MIDDLE EAST & AFRICA 7.3.5 SOUTH AMERICA 7.3.5.1 BRAZIL 7.3.5.2 ARGENTINA 7.3.5.3 REST OF SOUTH AMERICA 8. COMPETITIVE LANDSCAPE 8.1 MERGERS & ACQUISITION ANALYSIS 8.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 8.3 NEW PRODUCTS LAUNCHES 9. KEY PLAYERS 9.1 ABBOTT LABORATORIES 9.2 COMBIMATRIX CORPORATION 9.3 GE HEALTHCARE 9.4 SIGMA-TAU PHARMACEUTICALS, INC. 9.5 JOHNSON & JOHNSON 9.6 MALLINCKRODT PLC 9.7 MERCK & COMPANY, INC. 9.8 NANOSPHERE, INC. 9.9 PFIZER, INC. 9.10 CELGENE CORPORATION 9.11 OTHERS 10. FUTURE OF THE MARKET

ABBOTT LABORATORIES,COMBIMATRIX CORPORATION,GE HEALTHCARE,SIGMA-TAU PHARMACEUTICALS Inc.,JOHNSON & JOHNSON,MALLINCKRODT Plc,MERCK & COMPANY Inc.,NANOSPHERE Inc.,PFIZER,CELGENE CORPORATION